Duoback듀오백

Duoback remains loss-making with shrinking revenue, though its share price has risen sharply over three months.

Duoback, a Korean maker of ergonomic chairs, reported trailing twelve-month revenue of ₩22.2B to H1 2026 with an operating loss of ₩2.5B and a net loss of ₩4.0B. Revenue has fallen in each of the last several years, and the company has negative free cash flow of ₩3.5B. Recent filings show a change of CEO, an extraordinary shareholders' meeting, and a notice that the exchange is reviewing its listing eligibility.

What stands out

• Revenue fell 13% in 2025 to ₩20.1B, after declines in 2024 and 2023, and operating margins have been negative every year since 2021.
• Trailing net loss of ₩4.0B is larger than the operating loss, and ROE is -17.4%.
• Balance sheet shows cash of ₩2.3B against borrowings of ₩0.5B, with liabilities at 58.9% of equity.
• Shares closed at ₩1,622, up 93.1% over three months but flat over one month and down 9.6% over one year; the stock is about 17% below its 52-week high of ₩1,959.
• Price-to-book is 0.6 and price-to-sales is 0.9, with no earnings-based valuation available because the company is loss-making; it pays no dividend.

What to watch

• The filing that the exchange has subjected Duoback to a substantive review of listing eligibility, and any decision that follows.
• Governance changes: the CEO change (amended filing dated 2026-10-20) and the outcome of the extraordinary shareholders' meeting, with the CEO name not given in the data.
• Whether the company returns to operating profit and positive free cash flow in upcoming results; the data does not include forecasts.